20. 副腎白質ジストロフィー Adrenoleukodystrophy Clinical trials / Disease details


臨床試験数 : 61 薬物数 : 90 - (DrugBank : 31) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 126

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04973657
(ClinicalTrials.gov)
June 22, 202128/6/2021A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMNPhase 1b, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability, PD and PK of VK0214, in Subjects With the Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)Drug: VK0214;Other: PlaceboViking Therapeutics, Inc.NULLRecruiting18 YearsN/AAll36Phase 1United States